RxDoctor Payments Data

Kevin Brown

Foot & Ankle Surgery · Huntington, WVNPI 1811968555

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $29,400 of the $31,250 with a category attached, or 94.1%. Darco International, Inc. accounts for 94.1% of it on its own, with 16 other manufacturers making up the rest. Among foot & ankle surgery clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$31,250in general payments, 2019–2025

Across 66 payments — averaging $473.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Darco International, Inc.$29K
  • Stryker$552
  • Organogenesis Inc.$404
  • Smith+Nephew$349
  • Mid-atlantic Surgical Systems, LLC$118
  • Johnson & Johnson$89
  • plus $339 from 11 others

What the payments were for

  • Consulting fees$29,40094%
  • Food & beverage$1,3474%
  • Education$5032%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$31,250 in reported general payments places this provider in the 90th percentile of 36 foot & ankle surgery providers in West Virginia.

See all foot & ankle surgery providers in West Virginia

Medicare billing

Part B allowed, 2024
$333,265
Medicare patients
494
Services billed
4,306

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SantylCollagenase Clostridium Hist.11$4,227
Ciclopirox124$2,722
Ammonium Lactate102$1,741
Pregabalin70$1,049
Diclofenac Sodium87$953
Econazole Nitrate53$809
Indomethacin ErIndomethacin27$807
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen151$729
Celecoxib55$689
Ketoconazole36$531
Mupirocin64$514
Amitriptyline Hcl58$488
Doxycycline Hyclate75$443
Indomethacin22$390
Pentoxifylline11$350

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Smith+NephewSantyl$349$4,22711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 36 foot & ankle surgery providers in West Virginia.

Other foot & ankle surgery in Huntington

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →